The Analyst Report as published from time to time is included in our website as part of our stakeholders engagement initiatives. The inclusion of such report however does not imply our endorsement of or concurrence with such information, conclusions or recommendations.
| Date |
Analyst |
Title |
| Dec 02, 2021 |
CIMB Research |
A shot in the arm from new cloud contract |
| Mar 03, 2021 |
CIMB Research |
Riding on MyDigital initiatives |
| Feb 25, 2021 |
CIMB Research |
Expecting a weaker 2HFY21 |
| Feb 23, 2021 |
UOB KayHian |
Accelerating Digitalisation Via MyDigital Blueprint |
| Feb 19, 2021 |
RHB Research |
Ceasing Coverage |
| Nov 04, 2020 |
RHB Research |
Finally, Light At The End of The Tunnel? |
| Sep 17, 2020 |
RHB Research |
Microsoft Discontinuation a Knockout Blow? |
| Aug 28, 2020 |
RHB Research |
Funda-matters; Maintain SELL |
| Jul 24, 2020 |
RHB Research |
Raising War Chest Via Cash Call; Still SELL |
| Jul 22, 2020 |
RHB Research |
Dr Is In The House, Again |
| Apr 03, 2020 |
RHB Research |
Earnings Negativity Priced In; U/G To NEUTRAL |
| Feb 26, 2020 |
RHB Research |
Negative On Results, Positive On Divestment |
| Feb 26, 2020 |
CIMB Research |
2QFY6/20: Sequentially wider net loss |
| Jan 22, 2020 |
RHB Research |
Private Placement On The Cards; Still SELL |
| Dec 02, 2019 |
CIMB Research |
1QFY6/20: Low software profit margin |
| Sep 03, 2019 |
RHB Research |
No Sign Of Optimism As Yet; Still a SELL |
| May 31, 2019 |
RHB Research |
Lacking Catalyst After SKIN; Still a SELL |
| Apr 15, 2019 |
RHB Research |
Company claiming RM733m for loss of SKIN |
| Mar 01, 2019 |
RHB Research |
All Eyes On The Compensation; Still SELL |
| Sep 05, 2018 |
PublicInvest Research |
Secures Master Licensing Agreement 3.0 |
Next Page >
